tetano
Editor, Senior Moderator
Ann Transl Med. 2020 Apr;8(7):481. doi: 10.21037/atm.2020.03.61.
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.
Dai YJ[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Hu F[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Li H[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Huang HY[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Wang DW[SUP]4[/SUP], Liang Y[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Background:
The new coronavirus pneumonia (NCP) is now causing a severe public health emergency. The novel coronavirus 2019 (2019-nCoV) infected individuals by binding human angiotensin converting enzyme II (ACE2) receptor. ACE2 is widely expressed in multiple organs including respiratory, cardiovascular, digestive and urinary systems in healthy individuals. These tissues with high expression level of ACE2 seemed to be more vulnerable to SARS-CoV-2 infection. Recently, it has been reported that patients with tumors were likely to be more susceptible to SARS-CoV-2 infection and indicated poor prognosis.
Methods:
The tissue atlas database and the blood atlas were used to analyze the distribution of ACE2 in human tissues or organs of cancers and normal samples. Starbase dataset was applied to predict the prognosis of cancers according to expression level of ACE2.
Results:
In this study, we demonstrated a landscape profiling analysis on expression level of ACE2 in pan-cancers and showed the risky of different type of cancers to SARS-CoV-2 according to the expression level of ACE2. In addition, we found that ACE2 was both differential expression and related to the prognosis only in liver hepatocellular carcinoma (LIHC). Relative high expression of ACE2 indicated a favorable prognosis in LIHC, but they might be more susceptible to SARS-CoV-2.
Conclusions:
We indeed emphasized that LIHC patients with high expression level of ACE2 should be more cautious of the virus infection. Our study might provide a potential clue for preventing infection of SARS-CoV-2 in cancers.
2020 Annals of Translational Medicine. All rights reserved.
KEYWORDS:
SARS-CoV-2; angiotensin converting enzyme II (ACE2); cancer; liver hepatocellular carcinoma (LIHC)
PMID:32395525PMCID:PMC7210193DOI:10.21037/atm.2020.03.61
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.
Dai YJ[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Hu F[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Li H[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Huang HY[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Wang DW[SUP]4[/SUP], Liang Y[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Background:
The new coronavirus pneumonia (NCP) is now causing a severe public health emergency. The novel coronavirus 2019 (2019-nCoV) infected individuals by binding human angiotensin converting enzyme II (ACE2) receptor. ACE2 is widely expressed in multiple organs including respiratory, cardiovascular, digestive and urinary systems in healthy individuals. These tissues with high expression level of ACE2 seemed to be more vulnerable to SARS-CoV-2 infection. Recently, it has been reported that patients with tumors were likely to be more susceptible to SARS-CoV-2 infection and indicated poor prognosis.
Methods:
The tissue atlas database and the blood atlas were used to analyze the distribution of ACE2 in human tissues or organs of cancers and normal samples. Starbase dataset was applied to predict the prognosis of cancers according to expression level of ACE2.
Results:
In this study, we demonstrated a landscape profiling analysis on expression level of ACE2 in pan-cancers and showed the risky of different type of cancers to SARS-CoV-2 according to the expression level of ACE2. In addition, we found that ACE2 was both differential expression and related to the prognosis only in liver hepatocellular carcinoma (LIHC). Relative high expression of ACE2 indicated a favorable prognosis in LIHC, but they might be more susceptible to SARS-CoV-2.
Conclusions:
We indeed emphasized that LIHC patients with high expression level of ACE2 should be more cautious of the virus infection. Our study might provide a potential clue for preventing infection of SARS-CoV-2 in cancers.
2020 Annals of Translational Medicine. All rights reserved.
KEYWORDS:
SARS-CoV-2; angiotensin converting enzyme II (ACE2); cancer; liver hepatocellular carcinoma (LIHC)
PMID:32395525PMCID:PMC7210193DOI:10.21037/atm.2020.03.61